Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE: DNA · Real-Time Price · USD

12.37

+1.08 (9.57%)

At close: Nov 9, 2026, 4:00 PM EST

12.50

+0.13 (1.05%)

Pre-market: Nov 10, 2026, 6:01 AM EST

Ginkgo Bioworks Holdings Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	130.75	170.16	227.04	251.46	477.71	313.84
Revenue Growth	-18.30%	-25.06%	-9.71%	-47.36%	52.22%	309.40%
Gross Profit	91.25	123.18	182.5	197.45	273.49	184.15
Operating Income	-268.98	-308.11	-478.72	-733.83	-2,196	-1,828
Net Income	-251.03	-312.76	-547.03	-892.87	-2,105	-1,830
Earnings Per Share	-4.14	-5.64	-10.54	-18.37	-50.20	-55.53
EPS Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cell Engineering	93.34	132.75	173.97	143.53	143.67	112.99
Biosecurity Service	-	37.41	53.07	78.98	298.59	177.81
Revenue (Total)	-	170.16	227.04	251.46	477.71	313.84

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	285.36	422.62	561.57	944.07	1,316	1,550
Total Debt	397.2	439.89	467.73	239.31	442.59	23.03
Net Cash (Debt)	-111.84	-17.27	93.84	704.76	873.2	1,527
Net Cash Growth	-	-	-86.69%	-19.29%	-42.81%	319.73%
Net Cash Per Share	-1.84	-0.31	1.81	14.50	20.79	44.90

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-166.99	-171.06	-319.59	-295.5	-252.2	-253.82
Capital Expenditures	-6.56	-7.67	-62.54	-40.8	-52.27	-56.52
Free Cash Flow	-173.54	-178.72	-382.13	-336.3	-304.47	-310.34
Free Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	69.79%	72.39%	80.38%	78.52%	57.25%	58.68%
Operating Margin	-205.72%	-181.08%	-210.85%	-291.84%	-459.70%	-582.62%
Pretax Margin	-212.72%	-184.30%	-241.15%	-355.11%	-444.08%	-585.69%
Profit Margin	-191.99%	-183.81%	-240.94%	-355.08%	-440.63%	-583.12%
FCF Margin	-132.73%	-105.04%	-168.31%	-133.74%	-63.74%	-98.89%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	6.37	2.78	2.30	13.26	5.98	39.37